【Purpose】In recent years, the number of patients with chronic kidney disease (CKD) has increased with the increase in the number of elderly people. Patients with CKD frequently fall ill with congestive heart failure (CHF), which affects their life expectancy. Currently, evaluating vascular calcification (VC) is generally recommended as a predictive factor for CHF. However, a simpler method to evaluate VC quantitatively is needed. We examined whether abdominal aortic calcification score (AACS) is associated with the incidence of CHF and mortality among CKD patients in a prospective cohort study. 【Method】The study subjects were 72 chronic hemodialysis outpatients at a single dialysis center in January 2009. Clinical indicators, blood test samples, and AACS evaluated by abdominal plain X-ray were obtained at the baseline of this study. The subjects were divided into a high-AACS group (≧7) and a low-AACS group (<7), and were followed up with the incidence of CHF as a primary endpoint and mortality as a secondary endpoint for two years. 【Results】Using other clinical indicators and blood test samplings at baseline, the high-AACS group showed a longer duration of dialysis and higher serum calcium concentration than the low-AACS group. In each group, AACS was positively correlated with age (high-AACS group : r=0.21, p=0.002 ; low-AACS group : r=0.09, p=0.001) ; however, no correlation was observed with the duration of dialysis. In survival analysis, the high-AACS group had an increased chance of CHF (log-rank test : χ
2=5.69, p=0.02) and mortality (χ
2=4.21, p=0.04). By Cox hazard analysis, no significant difference was observed, possibly due to the small sample size. 【Conclusion】Although further evaluations are needed, AACS is a potential predictive factor for CHF and mortality among chronic hemodialysis patients.
View full abstract